27 /100
MEDIUM RISK
Score updated May 30, 2026

RYTM — Rhythm Pharmaceuticals, Inc. Dilution Risk Tracker

Track RYTM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RYTM — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for RYTM.
🔔 Track RYTM — Get forecast alerts →

💹 Market Data

Market Cap$6.05B
Shares Outstanding68.53M
Float55.70M
Cash$340.62M
Debt$112.31M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 84.8% shares (2025Q4 vs prior)
280 institutional holders · 74.73M shares
#1 RA CAPITAL MANAGEMENT, L.P. 6.67M shares
#2 BlackRock, Inc. 6.30M shares
#3 VANGUARD GROUP INC 6.21M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest8.28M
Days to Cover8.3
% of Float14.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2015
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track RYTM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RYTM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for RYTM
📊 RYTM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RYTM Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.